z-logo
open-access-imgOpen Access
T-cell factor/β-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease
Author(s) -
Michelle M. Miller,
Diana M. Iglesias,
Zhao Zhang,
Rachel Corsini,
LeeLee Chu,
Inga J. Murawski,
Indra R. Gupta,
Stefan Somlo,
Gregory G. Germino,
Paul Goodyer
Publication year - 2011
Publication title -
kidney international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.499
H-Index - 276
eISSN - 1523-1755
pISSN - 0085-2538
DOI - 10.1038/ki.2011.56
Subject(s) - disease , autosomal dominant polycystic kidney disease , medicine , polycystic kidney disease , kidney disease , catenin , cancer research , cell , endocrinology , beta catenin , biology , microbiology and biotechnology , genetics , wnt signaling pathway , signal transduction
During murine kidney development, canonical WNT signaling is highly active in tubules until about embryonic days E16-E18. At this time, β-catenin transcriptional activity is progressively restricted to the nephrogenic zone. The cilial protein genes PKD1 and PKD2 are known to be mutated in autosomal dominant polycystic kidney disease (ADPKD), and previous studies proposed that these mutations could lead to a failure to suppress canonical WNT signaling activity. Several in vitro studies have found a link between cilial signaling and β-catenin regulation, suggesting that aberrant activity might contribute to the cystic phenotype. To study this, we crossed T-cell factor (TCF)/β-catenin-lacZ reporter mice with mice having Pkd1 or Pkd2 mutations and found that there was no β-galactosidase staining in cells lining the renal cysts. Thus, suppression of canonical WNT activity, defined by the TCF/β-catenin-lacZ reporter, is normal in these two different models of polycystic kidney disease. Hence, excessive β-catenin transcriptional activity may not contribute to cystogenesis in these models of ADPKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom